Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D01BA02 TERBINAFINUM COMPR. 250 mg

LAMISIL(R) 250 mg NOVARTIS PHARMA GMBH

TERBINARAN 250 mg RANBAXY UK LIMITED

TERBISIL(R) 250 mg 250 mg GEDEON RICHTER LTD.
______________________________________________________________________________

| 227 |D05AX02| CALCIPOTRIOLUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D05AX02 CALCIPOTRIOLUM CREMA 50 µg/g

DAIVONEX 50 µg/g LEO PHARMACEUTICAL

PRODUCTS
D05AX02 CALCIPOTRIOLUM UNGUENT 50 µg/g

DAIVONEX UNGUENT 50 µg/g LEO PHARMACEUTICAL

PRODUCTS
D05AX02 CALCIPOTRIOLUM SOL. CUT. 50 µg/ml

DAIVONEX SOLUŢIE CUTANATĂ 50 µg/ml LEO PHARMACEUTICAL

PENTRU SCALP PRODUCTS

D05AX02 CALCIPOTRIOLUM UNGUENT 0.005%

SOREL(R) unguent 0,005% 0.005% LEK PHARMACEUTICALS D.D.

______________________________________________________________________________

| 228 |D05AX52| COMBINATII (CALCIPOTRIOLUM + | |

| | | BETAMETHASONUM)* | |

|_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D05AX52 COMBINATII UNGUENT

(CALCIPOTRIOLUM +

BETAMETHASONUM)

DAIVOBET(R) UNGUENT LEO PHARMACEUTICAL

PRODUCTS
______________________________________________________________________________

| 230 |D06AX01| ACIDUM FUSIDICUM | |

|_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D06AX01 ACIDUM FUSIDICUM CREMA 2,00%

FUCIDIN(R) 2% LEO PHARMACEUTICAL

PRODUCTS

D06AX01 ACIDUM FUSIDICUM UNGUENT 2,00%

FUCIDIN(R) 2% LEO PHARMACEUTICAL

PRODUCTS
______________________________________________________________________________

| 231 |D06AXN1| COMBINATII (NEOMYCINUM + BACITRACINUM) | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D06AXN1 COMBINATII PULB. CUT.

(NEOMYCINUM +

BACITRACINUM)

BANEOCIN(R) SANDOZ GMBH
D06AXN1 COMBINATII UNGUENT

(NEOMYCINUM +

BACITRACINUM)

BANEOCIN(R) SANDOZ GMBH

NEOBACIN DAR AL DAWA PHARMA SRL
______________________________________________________________________________

| 232 |D06BA01| SULFADIAZINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D06BA01 SULFADIAZINUM CREMA 1,00%

DERMAZIN(R) 1% 1% LEK PHARMACEUTICALS D.D.
______________________________________________________________________________

| 233 |D06BB04| PODOPHYLLOTOXINUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D06BB04 PODOPHYLLOTOXINUM CREMA 1,5 mg/g

WARTEC 1,5 mg/g 1,5 mg/g STIEFEL LABORATORIES (UK)

LTD.
D06BB04 PODOPHYLLOTOXINUM SOL. CUT. 5 mg/ml

CONDYLINE 5 mg/ml ASTELLAS PHARMA EUROPE

B.V.
Prescriere limitată: Pentru tratamentul verucilor.

______________________________________________________________________________

| 235 |D07AB02| HYDROCORTISONUM BUTYRATUM | Protocol: D001L |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07AB02 HYDROCORTISONUM CREMA 0.1%

BUTYRATUM

LOCOID(R) cremă 0,1% 0.1% ASTELLAS PHARMA EUROPE BV

LOCOID(R)LIPOCREAM 0,1% 0.1% ASTELLAS PHARMA EUROPE

B.V.

D07AB02 HYDROCORTISONUM EMULSIE CUT. 0.1%

BUTYRATUM

LOCOID CRELO(R) 0,1% 0.1% ASTELLAS PHARMA EUROPE BV
D07AB02 HYDROCORTISONUM SOL. CUT. 0.1%

BUTYRATUM

LOCOID(R) 0.1% ASTELLAS PHARMA EUROPE

B.V.
______________________________________________________________________________

| 236 |D07AC13| MOMETASONUM | Protocol: D001L |

|_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07AC13 MOMETASONUM CREMA 1 mg/g

ELOCOM 1 mg/g SCHERING PLOUGH EUROPE
D07AC13 MOMETASONUM SOL. CUT. 1 mg/g

ELOCOM 1 mg/g SCHERING PLOUGH EUROPE

D07AC13 MOMETASONUM UNGUENT 1 mg/g

ELOCOM 1 mg/g SCHERING PLOUGH EUROPE

______________________________________________________________________________

| 237 |D07AC14| METHYLPREDNISOLONUM ACEPONAT | Protocol: D001L |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07AC14 METHYLPREDNISOLONUM EMULSIE CUT. 0.1%

ACEPONAT

ADVANTAN(R) MILK 0.1% INTENDIS GMBH

D07AC14 METHYLPREDNISOLONUM CREMA 1 mg/g

ACEPONAT

ADVANTAN 1 mg/g INTENDIS GmbH
D07AC14 METHYLPREDNISOLONUM UNGUENT 1 mg/g

ACEPONAT

ADVANTAN 1 mg/g INTENDIS GmbH
______________________________________________________________________________

| 238 |D07AC17| FLUTICASONUM | Protocol: D001L |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07AC17 FLUTICASONUM CREMA 0.05%

CUTIVATE 0.05% GLAXO WELLCOME UK LIMITED
D07AC17 FLUTICASONUM UNGUENT 0.005%

CUTIVATE 0.005% GLAXO WELLCOME UK LIMITED

______________________________________________________________________________

| 239 |D07AD01| CLOBETASOLUM* | Protocol: D001L |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07AD01 CLOBETASOLUM CREMA 0.05%

DERMOVATE 0.05% GLAXOWELLCOME UK LTD.
D07AD01 CLOBETASOLUM SOL. CUT. 0.05%

DERMOVATE(R) 0.05% GLAXO WELLCOME UK LTD.

D07AD01 CLOBETASOLUM UNGUENT 0.05%

DERMIONE 0.05% OZONE LABORATORIES LTD.

DERMOVATE 0.05% GLAXOWELLCOME UK LTD.
______________________________________________________________________________

| 240 |D07CA01| COMBINATII (HYDROCORTISONUM + | Protocol: D001L |

| | | ANTIINFECTIOASE) | |

|_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07CA01 COMBINATII CREMA

(HYDROCORTISONUM +

ANTIINFECTIOASE)

FUCIDIN(R) H LEO PHARMACEUTICAL

PRODUCTS

PIMAFUCORT ASTELLAS PHARMA EUROPE

B.V.
D07CA01 COMBINATII UNGUENT

(HYDROCORTISONUM +

ANTIINFECTIOASE)

PIMAFUCORT ASTELLAS PHARMA EUROPE

B.V.
______________________________________________________________________________

| 241 |D07CC01| COMBINATII (BETAMETHASONUM + | Protocol: D001L |

| | | ANTIINFECTIOASE) | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07CC01 COMBINATII CREMA

(BETAMETHASONUM +

ANTIINFECTIOASE)

FUCICORT(R) LEO PHARMACEUTICAL

PRODUCTS
______________________________________________________________________________

| 242 |D07XC03| COMBINATII (MOMETASONUM + | Protocol: D001L |

| | | AC. SALICILICUM) | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07XC03 COMBINATII UNGUENT

(MOMETASONUM + AC.

SALICILICUM)

ELOSALIC SCHERING PLOUGH EUROPE
______________________________________________________________________________

| 243 |D10AD54| COMBINATII (MOMETASONUM + ERITROMICINUM) | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D10AD54 COMBINATII GEL 0,05%/0,2%

(ISOTRETINOINUM +

ERITROMICINUM)

ISOTREXIN GEL 0,05%/0,2% STIEFEL LABORATORIES (UK)

LTD.
______________________________________________________________________________

| 244 |D10AX03| ACIDUM AZELAICUM | |

|_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D10AX03 ACIDUM AZELAICUM CREMA 200 mg/g

SKINOREN 200 mg/g INTENDIS GmbH
D10AX03 ACIDUM AZELAICUM GEL 15%

SKINOREN(R) 15% 15% INTENDIS GMBH

______________________________________________________________________________

| 245 |D10BA01| ISOTRETINOINUM** | |

|_______|_______|____________________________________________|_________________|